[Long term sequelae of otitis media with effusion during childhood]

Elzbieta Hassmann-Poznańska1, Artur Goździewski, Małgorzata Piszcz

  • 1Klinika Otolaryngologii Dzieciecej, Uniwersytetu Medycznego w Białymstoku. pedorl@umwb.edu.pl

Insights

Tympanostomy tubes effectively improve hearing in children with otitis media with effusion short-term, but long-term follow-up is crucial due to recurrence and tympanic membrane sequelae risks.

Area of Science:

  • Otolaryngology
  • Pediatric Audiology
  • Middle Ear Disease

Context:

  • Otitis media with effusion (OME) is a primary cause of childhood hearing loss.
  • Myringotomy with tympanostomy tube insertion is a common treatment for OME.
  • Long-term outcomes of tympanostomy tube insertion for chronic OME require evaluation.

Purpose:

  • To assess treatment outcomes, middle ear sequelae incidence, and hearing results in children with chronic OME post-tympanostomy tube insertion.
  • To determine the long-term effects of tympanostomy tubes on the tympanic membrane and hearing.

Summary:

  • A cohort of 97 children treated with tympanostomy tubes were re-evaluated after a mean of 7.3 years.
  • Recurrent OME occurred in 23.7% of patients; 16.5% had ongoing issues or tympanic membrane abnormalities at follow-up.
  • Common sequelae included focal atrophy (67.2%) and myringosclerosis (39.5%), with minor hearing threshold differences (≤6.5 dB HL).

Impact:

  • Tympanostomy tubes offer short-term hearing improvement but do not prevent long-term tympanic membrane sequelae or persistent hearing loss.
  • Prolonged follow-up is recommended for children treated with tympanostomy tubes due to recurrence rates.
  • Treatment decisions should consider spontaneous resolution potential and long-term risks.
Abstract

Related Concept Videos

Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Tonsillitis I: Introduction01:30

Tonsillitis I: Introduction

Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Brain Abscess l: Introduction01:26

Brain Abscess l: Introduction

A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...